Compare FC & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FC | MDXH |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.2M | 167.8M |
| IPO Year | 1992 | 2021 |
| Metric | FC | MDXH |
|---|---|---|
| Price | $16.83 | $3.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $24.50 | $7.67 |
| AVG Volume (30 Days) | ★ 124.2K | 118.6K |
| Earning Date | 01-07-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $267,067,000.00 | $103,069,000.00 |
| Revenue This Year | $2.82 | $23.34 |
| Revenue Next Year | $4.35 | $22.98 |
| P/E Ratio | $70.70 | ★ N/A |
| Revenue Growth | N/A | ★ 21.68 |
| 52 Week Low | $14.04 | $1.35 |
| 52 Week High | $39.22 | $5.33 |
| Indicator | FC | MDXH |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 45.52 |
| Support Level | $16.63 | $3.20 |
| Resistance Level | $17.48 | $3.58 |
| Average True Range (ATR) | 0.47 | 0.19 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 51.70 | 58.00 |
Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.